Pharmacists in Scotia, CA Accepting Medicare
2 Pharmacists found. Showing 1 - 2
 Mr. George Dennis Peck, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 113 Main St., Suite D, Scotia, CA 95565 Phone: 707-764-3591 Fax: 707-764-3797 |
 Merilyn Dunn Ross, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 113 Main St, Suite D, Scotia, CA 95565 Phone: 707-764-3591 Fax: 707-764-3797 |
News Archive
Second Peace Corps volunteer reports being discharged after testing HIV-positive, Washington Post reports
Washington Post columnist Stephen Barr on Friday examined the case of a second Peace Corps volunteer who said she was discharged from service after testing HIV-positive. Rebecca Coulborn, a former volunteer in Burkina Faso, said she was required to leave her post immediately in 2001 after she tested positive for the virus.
New technique allows better understanding of cellular stress reaction
Stress in the body's cells is both the cause and consequence of inflammatory diseases or cancer. The cells react to stress to protect themselves. Researchers at the University of Zurich have now developed a new technique that allows studying a fundamental response to stress in much more detail than previously possible: the ADP-ribosylation of chromatin.
Protein serum amyloid A could be a potential diagnostic biomarker for lung cancer
Scientists are reporting discovery of a protein in the blood of lung cancer patients that could be used in a test for the disease - difficult to diagnose in its earliest and most treatable stages - and to develop drugs that stop lung cancer from spreading. Their study appears in ACS's Journal of Proteome Research.
Fallujah doctors say chemicals from U.S. weapons to blame for high levels of birth defects
"While the U.S. military has formally withdrawn from Iraq, doctors and residents of Fallujah are blaming weapons like depleted uranium and white phosphorous used during two devastating U.S. attacks on Fallujah in 2004 for what are being described as 'catastrophic' levels of birth defects and abnormalities," Al Jazeera reports.
FDA approves first treatment to reduce risk of NSCLC progression
The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).
› Verified 9 days ago